Skip to content
PaperFren

Critical care

Can ferritin flag deadly macrophage-like sepsis?

Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. · BMC medicine · 2017

Open access · cc by · source: Europe PMC

In 5,121 Greek patients with infection and SIRS, macrophage activation-like syndrome (MALS) occurred in ~4% and independently predicted 10-day death; ferritin above 4420 ng/ml marked ~66% 28-day mortality.

Study at a glance

Design
Cohort — Prospective Greek sepsis cohorts (test n=3417, validation n=1704) plus a Swedish ferritin-validation cohort (n=109) classifying macrophage activation-like syndrome (MALS)
N
N=5121 · 3417 test + 1704 validation patients with infection and SIRS; ferritin repeated on day 3 in 747; Swedish cohort n=109
Population
Adults with infection plus SIRS enrolled by the Hellenic Sepsis Study Group (plus an independent Swedish sepsis cohort)
Outcome
MALS frequency, 10-day mortality, and ferritin as a diagnostic/prognostic biomarker

Structured fields used in claim comparison tables when every cited study has a complete layer.

Key findings

MALS frequency was 3.7% (test) and 4.3% (validation). Ferritin >4420 ng/ml had >97% specificity for MALS and 66.7%/66% 28-day mortality (OR 4.07 in the test cohort). A <15% day-3 ferritin drop had >90% sensitivity for 10-day death.

Methodology

Assigned patients to test (n=3417) and validation (n=1704) cohorts, defined MALS by HScore and/or DIC plus hepatobiliary dysfunction, measured ferritin and cytokines, and checked 10-day mortality; ferritin was repeated on day 3 in 747 patients and in 109 Swedish patients.

Limitations

This observational classification does not prove that treating high-ferritin MALS (e.g., with anakinra) saves lives; HScore was modified without bone-marrow hemophagocytosis, so MALS is not identical to classic MAS.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.

Related papers in this topic

Same topic cluster — not a recommendation engine.